Francesco Andreozzi
Francesco Andreozzi publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology, on topics such as Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Cardiovascular Function and Risk Factors.
- World rank
- #281,488 of 7,710,434 ranked researchers
- Rank in Italy
- #6,962 of 242,206
- Works
- 304
- Citations
- 9k
- Citations per work
- 29.7
What does Francesco Andreozzi research?
Francesco Andreozzi's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences17758.2%
- Medicine17758.2%
- Everything else9631.5%
- Life Sciences3110.3%
- 1Endocrinology, Diabetes and Metabolism22% of their works
- 2Cardiology and Cardiovascular Medicine16% of their works
- 3Molecular Biology10% of their works
- 4Epidemiology8% of their works
- 5Surgery6% of their works
- 6Physiology6% of their works
Research topics
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Cardiovascular Function and Risk Factors
- Adipokines, Inflammation, and Metabolic Diseases
- Cardiovascular Health and Disease Prevention
- Metabolism, Diabetes, and Cancer
- Liver Disease Diagnosis and Treatment
- Pancreatic function and diabetes
Which keywords describe Francesco Andreozzi's research?
The keywords of their largest research topics: Obesity, Insulin Resistance, Metabolic Syndrome, Cardiovascular Disease, Heart Failure, Type 2 Diabetes, Diabetes and Glucose Metabolism.
- ß-Cell Dysfunction
- NASH
- Metformin
- Endothelial Dysfunction
- Inflammation
- Chamber Quantification
- Glucose Control
- Glucose Metabolism
- Type 2 Diabetes
- Cardiovascular Disease
- Insulin Resistance
- Obesity
- Metabolic Syndrome
- Heart Failure
- Diabetes
- Cardiovascular Outcomes
- Adipose Tissue
- Echocardiography
- Arterial Stiffness
- AMP-Activated Protein Kinase
- NAFLD
- Pancreatic Islets
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Obesity1513 topics
- Insulin Resistance1403 topics
- Metabolic Syndrome1403 topics
- Cardiovascular Disease1122 topics
- Heart Failure832 topics
- Type 2 Diabetes832 topics
- Diabetes731 topic
- Glucose Metabolism731 topic
- Cardiovascular Outcomes441 topic
- Glucose Control441 topic
- Adipose Tissue391 topic
- Chamber Quantification391 topic
- Echocardiography391 topic
- Inflammation391 topic
- Arterial Stiffness351 topic
- Endothelial Dysfunction351 topic
- AMP-Activated Protein Kinase331 topic
- Metformin331 topic
- NAFLD281 topic
- NASH281 topic
- Pancreatic Islets281 topic
- ß-Cell Dysfunction281 topic
Where does Francesco Andreozzi work?
Francesco Andreozzi's main affiliation in the publication record is Magna Graecia University, Italy.
How many publications and citations does Francesco Andreozzi have?
OpenAlex counts 304 works and 9,041 citations for Francesco Andreozzi, an h-index of 52, ranking #281,488 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Francesco Andreozzi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.